Evolent Health Inc (EVH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Evolent Health Inc (EVH) has a cash flow conversion efficiency ratio of -0.002x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-984.00K) by net assets ($396.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Evolent Health Inc (EVH) balance sheet quality index to measure how much of total assets are equity-financed.
Evolent Health Inc - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Evolent Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Evolent Health Inc (EVH) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Evolent Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evolent Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aclaris Therapeutics Inc
NASDAQ:ACRS
|
-0.091x |
|
Tederic Machinery Co Ltd
SHG:603289
|
0.020x |
|
Brunel International NV
AS:BRNL
|
0.153x |
|
Acco Brands Corporation
NYSE:ACCO
|
0.005x |
|
Ferm. Casino Mun. Canne
PA:FCMC
|
0.020x |
|
Ipd Group Ltd
AU:IPG
|
0.062x |
|
Protec Co. Ltd
KQ:053610
|
-0.031x |
|
Zhejiang Dibay Electric Co Ltd
SHG:603320
|
0.023x |
Annual Cash Flow Conversion Efficiency for Evolent Health Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of Evolent Health Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see EVH market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $415.19 Million | $38.84 Million | 0.094x | +399.18% |
| 2024-12-31 | $1.00 Billion | $18.77 Million | 0.019x | -85.97% |
| 2023-12-31 | $1.07 Billion | $142.58 Million | 0.134x | +1093.40% |
| 2022-12-31 | $859.42 Million | $-11.55 Million | -0.013x | -124.06% |
| 2021-12-31 | $693.63 Million | $38.75 Million | 0.056x | +313.32% |
| 2020-12-31 | $619.60 Million | $-16.23 Million | -0.026x | +42.95% |
| 2019-12-31 | $929.05 Million | $-42.65 Million | -0.046x | -164.36% |
| 2018-12-31 | $1.19 Billion | $-20.65 Million | -0.017x | +35.02% |
| 2017-12-31 | $1.05 Billion | $-27.96 Million | -0.027x | +31.36% |
| 2016-12-31 | $912.11 Million | $-35.51 Million | -0.039x | -83.49% |
| 2015-12-31 | $934.58 Million | $-19.83 Million | -0.021x | -100.06% |
| 2014-12-31 | $-2.07 Million | $-75.09 Million | 36.277x | +8363.21% |
| 2013-12-31 | $31.04 Million | $-13.63 Million | -0.439x | +82.12% |
| 2012-12-31 | $5.20 Million | $-12.77 Million | -2.455x | -- |
About Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics an… Read more